ShambaviDRichardMD

PubMed

• 3 citations
  Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups.
  Urvi A Shah, Erin Moshier, Andriy Derkach, Yuanhui Huang, Sham Mailankody, Carlyn R Tan, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Hani Hassoun, Santiago Thibaud...> ;Blood Advances. 2024 Jan 9
• 4 citations
  IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies.
  Guido Lancman, Kian Parsa, Krzysztof Kotlarz, Lisa Avery, Alaina Lurie, Alex Lieberman-Cribbin, Hearn Jay Cho, Samir S Parekh, Shambavi Richard, Joshua Richter, Adrian...> ;Blood Cancer Discovery. 2023 Nov 1
• 1 citations
  Trial designs and endpoints for immune therapies in multiple myeloma.
  Guido Lancman, Erin Moshier, Hearn Jay Cho, Samir Parekh, Shambavi Richard, Joshua Richter, Adriana Rossi, Larysa Sanchez, Sundar Jagannath, Ajai Chari, Rodriguez, C.> ;American Journal of Hematology. 2023 Mar 1
• 22 citations
  Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
  Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T Melnekoff, Yogita Ghodke-Puranik, Gunjan L Shah, Alexander Lesokhin, Serg...> ;Blood. 2023 Feb 16
• 1 citations
  Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support.
  Tarek H Mouhieddine, Erin Moshier, Santiago Thibaud, Benjamin Puliafito, Mohammad Rattu, Rita Jakubowski, Larysa Sanchez, Adriana Rossi, Cesar Rodriguez, Shambavi Rich...> ;Bone Marrow Transplantation. 2023 Jan 1
• 8 citations
  A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma.
  Paula Restrepo, Sherry Bhalla, Yogita Ghodke-Puranik, Adolfo Aleman, Violetta Leshchenko, David T Melnekoff, Sarita Agte, Joy Jiang, Deepu Madduri, Joshua Richter, Sha...> ;JCO Precision Oncology. 2022 Jun 1
• 5 citations
  Targeting Nuclear Export Proteins in Multiple Myeloma Therapy.
  Shambavi Richard, Sundar Jagannath> ;Biodrugs. 2022 Jan 1
• 28 citations
  Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications.
  Sherry Bhalla, David Melnekoff, Adolfo Aleman, Violetta V. Leshchenko, Paula Restrepo, Jonathan J Keats, Kenan Onel, Jeffrey R. Sawyer, Deepu Madduri, Joshua Richter, ...> ;Science Advances. 2021 Nov 19
• 3 citations
  The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma
  Anthony D. Nehlsen, Kunal K. Sindhu, Erin Moshier, Joshua Richter, Shambavi Richard, Ajai Chari, Larysa Sanchez, Samir Parekh, Hearn Jay Cho, Sundar Jagannath, Kavita ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Sep 24
• A combination of carfilzomib, dexamethasone, and daratumumab for treatment of adult patients with relapsed/refractory multiple myeloma in two dosing regimens: once-wee...
  Xavier Leleu, Ajai Chari, Shambavi Richard, Monica Khurana, Akeem Yusuf, Saad Z. Usmani> ;Expert Review of Hematology. 2021 Sep 21
• 1 citations
  Treatment Bridging With a 28-Day Metronomic Therapy (Metro-28) for Relapsed Refractory Multiple Myeloma
  Tarek H. Mouhieddine, Julia Hieulle, Erin Moshier, Shambavi Richard, Joshua Richter, Hearn Jay Cho, Samir Parekh, Bart Barlogie, Ajai Chari, Sundar Jagannath, Deepu Ma...> ;Clinical Lymphoma Myeloma and Leukemia. 2021 Sep 11
• 37 citations
  Bispecific Antibodies in Multiple Myeloma: Present and Future.
  Guido Lancman, Dahniel Sastow, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Parekh, Shambavi Richard, Joshua Richter, Larysa Sanchez, Ajai Chari> ;Blood Cancer Discovery. 2021 Aug 17
• 14 citations
  Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.
  Shambavi Richard, Ajai Chari, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Ludek Pour, Iryna Kriachok, Meletios A. Dimopoulos, Halyna Pylypenko, Holger W. Auner, X...> ;American Journal of Hematology. 2021 Jul 5
• 7 citations
  Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma.
  Thomas G. Martin, Nina Shah, Joshua Richter, David H. Vesole, Sandy W. Wong, Chiung Yu Huang, Deepu Madduri, Sundar Jagannath, David S. Siegel, Noa Biran, Jeffrey L. W...> ;Cancer. 2021 Jun 1
• 10 citations
  Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma
  Guido Lancman, Katleen S Lozada, Nida Athar, Samantha E. Jacobs, John Doucette, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Parekh, Shambavi Richard, Joshua ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 May 1
• 21 citations
  B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies.
  Larysa Sanchez, Alexandra Dardac, Deepu Madduri, Shambavi Richard, Joshua Richter> ;Therapeutic Advances in Hematology. 2021 Jan 30
• 7 citations
  Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
  Larysa Sanchez, Joshua Richter, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Parekh, Shambavi Richard, Lowena Tam, Daniel Verina, Ajai Chari> ;Therapeutic Advances in Hematology. 2021 Jan 22
• 5 citations
  A comprehensive overview of daratumumab and carfilzomib and the recently approved daratumumab, carfilzomib and dexamethasone regimen in relapsed/refractory multiple my...
  Shambavi Richard, Sundar Jagannath, Hearn Jay Cho, Samir Parekh, Deepu Madduri, Joshua Richter, Ajai Chari> ;Expert Review of Hematology. 2021 Jan 2
• 9 citations
  Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based review.
  Larysa Sanchez, Kevin Barley, Joshua Richter, Joseph K. Franz, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Parekh, Shambavi Richard, Ajai Chari> ;Expert Review of Hematology. 2020 Aug 30
• 86 citations
  A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
  Bo Wang, Oliver Van Oekelen, Tarek H. Mouhieddine, Diane Marie Del Valle, Joshua Richter, Hearn Jay Cho, Shambavi Richard, Ajai Chari, Sacha Gnjatic, Miriam Merad, Sun...> ;Journal of Hematology & Oncology. 2020 Jul 14
• 28 citations
  Selinexor in relapsed/refractory multiple myeloma.
  Joshua Richter, Deepu Madduri, Shambavi Richard, Ajai Chari> ;Therapeutic Advances in Hematology. 2020 Jun 9
• 9 citations
  Selinexor: a first-in-class SINE compound for treatment of relapsed refractory multiple myeloma.
  Shambavi Richard, Joshua Richter, Sundar Jagannath> ;Future Oncology. 2020 Jun 8
• 18 citations
  A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
  Bo Wang, Oliver Van Oekelen, Tarek H. Mouhieddine, Diane Marie Del Valle, Joshua Richter, Hearn Jay Cho, Shambavi Richard, Ajai Chari, Sacha Gnjatic, Miriam Merad, Sun...> ;Medrxiv. 2020 Jun 5
• 31 citations
  Myeloma CAR-T CRS Management With IL-1R Antagonist Anakinra
  Shashidhar S. Jatiani, Adolfo Aleman, Deepu Madduri, Ajai Chari, Hearn Jay Cho, Shambavi Richard, Joshua Richter, Joshua Brody, Sundar Jagannath, Samir Parekh> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 May 11
• 12 citations
  Stem cell transplantation and hematopoietic growth factors.
  Shambavi Richard, Michael W Schuster> ;Current Hematology Reports. 2002 Nov 1
• Join now to see all

Abstracts/Posters

• Outcomes in Multiple Myeloma Patients Progressing on Lenalidomide Maintenance
  Shambavi Richard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019